← Back to Search

Brief Cognitive-Behavioral Therapy for Health Anxiety for Health Anxiety

N/A
Waitlist Available
Led By Robert E Brady, PhD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary care visit frequency of two standard deviations above the mean for patients in the individual's age by gender cohort
Diagnosis of illness anxiety disorder or somatic symptom disorder determined by Health Anxiety Interview
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 to 15 months before baseline
Awards & highlights

Study Summary

This trial is testing whether a brief cognitive-behavioral intervention delivered by medical assistants can help reduce health anxiety. The intervention consists of four sessions of individually administered cognitive-behavioral therapy. Treatment focuses on building motivation for change, psychoeducation about health anxiety, cognitive restructuring, and situational and interoceptive exposure. The study will recruit from three primary care clinics within the Dartmouth-Hitchcock Health system.

Who is the study for?
This trial is for adults aged 18-85 with health anxiety or somatic symptom disorder, who see their primary care provider often and have high self-reported health anxiety. They must be patients at specific Dartmouth-Hitchcock clinics and speak English. Those with chronic illnesses requiring frequent visits, unmanaged psychosis or bipolar disorder, or active suicidal thoughts cannot join.Check my eligibility
What is being tested?
The study tests a short cognitive-behavioral therapy (CBT) for health anxiety in primary care versus usual care which involves referral to a mental health provider. The CBT includes four sessions focusing on motivation, education about health anxiety, thought restructuring, and exposure exercises. Outcomes are measured over 12 weeks post-treatment.See study design
What are the potential side effects?
Since this trial involves psychological therapy rather than medication, traditional side effects are not expected; however participants may experience discomfort when confronting anxieties during the therapeutic process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I visit my primary care doctor much more often than most people my age and gender.
Select...
I have been diagnosed with health anxiety or somatic symptom disorder.
Select...
I am between 18 and 85 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 to 15 months before baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 to 15 months before baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in health anxiety, measured by the Short Health Anxiety Inventory
Secondary outcome measures
Acceptability of the intervention, measured by the Treatment Evaluation Inventory-Short Form
Change in readiness for intervention, measured by the University of Rhode Island Change Assessment-Psychotherapy Version
Other outcome measures
Determination of health anxiety diagnoses, assessed by the Health Anxiety Interview
Fidelity to the intervention following training, measured by the Cognitive Therapy Scale-Revised
Measurement of health anxiety for screening purposes, assessed by the Whiteley Index-7
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Referral to mental health providerExperimental Treatment1 Intervention
Provider makes referral to a mental health provider
Group II: Cognitive-Behavioral TherapyExperimental Treatment1 Intervention
Brief Cognitive-Behavioral Therapy for Health Anxiety

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor
521 Previous Clinical Trials
2,542,309 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,774 Previous Clinical Trials
2,674,213 Total Patients Enrolled
Robert E Brady, PhDPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Media Library

Brief Cognitive-Behavioral Therapy for Health Anxiety Clinical Trial Eligibility Overview. Trial Name: NCT03789084 — N/A
Health Anxiety Research Study Groups: Cognitive-Behavioral Therapy, Referral to mental health provider
Health Anxiety Clinical Trial 2023: Brief Cognitive-Behavioral Therapy for Health Anxiety Highlights & Side Effects. Trial Name: NCT03789084 — N/A
Brief Cognitive-Behavioral Therapy for Health Anxiety 2023 Treatment Timeline for Medical Study. Trial Name: NCT03789084 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently openings for individuals to participate in this experiment?

"According to clinicaltrials.gov, this particular medical trial is no longer actively enrolling candidates. The study was initially posted on March 26th 2019 and the last update took place July 21st 2022; however, there are still 1,236 other studies that require participants at present."

Answered by AI

Is eligibility for this trial limited to those aged 80 or younger?

"As outlined in the study's eligibility requirements, only individuals aged 18 to 85 can be recruited. For people under 18 and above 65, there are 327 trials and 826 trials respectively."

Answered by AI

Are there opportunities for me to engage with this medical experiment?

"Individuals suffering from anxiety disorders and within the 18-85 age range can qualify for this medical trial. Currently, 90 applicants are being sought out to partake in it."

Answered by AI
~0 spots leftby Mar 2024